Medicare Enrolled

Dr. Gerald Sokol, M.D.

Hematology · Cleveland, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
CLEVELAND CLINIC 9500 EUCLID AVE, Cleveland, OH 44195
4197562122
In practice since 2006 (20 years)
NPI: 1174590707 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sokol from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sokol? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sokol

Dr. Gerald Sokol is a hematology specialist in Cleveland, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sokol performed 490 Medicare services across 209 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sokol received a total of $76,627 from 64 pharmaceutical and/or device companies across 279 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sokol is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 17% volume in OH $76,627 industry payments

Medicare Practice Summary

Medicare Utilization ↗
490
Medicare services
Top 17% in OH for hematology
209
Unique beneficiaries
$147
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~24 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Intensity-modulated radiation therapy delivery
Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session.
153 $255 $695
CT guidance for radiation therapy
This procedure uses computed tomography imaging to guide the precise placement of radiation therapy fields. It ensures accurate positioning for targeted treatment delivery.
103 $92 $237
Stereoscopic X-ray guidance for radiation therapy localization
This procedure uses stereoscopic X-ray imaging to precisely locate the target area for radiation therapy delivery.
89 $52 $144
Radiation therapy, 3+ areas, 11-19 MeV
Delivery of high-energy radiation (11-19 MeV) to three or more separate treatment areas using custom blocking, tangential ports, wedges, rotational beams, and compensators.
30 $176 $458
Radiation therapy, 3+ areas, 6-10 MeV
Radiation treatment delivered to three or more separate areas using advanced techniques like custom blocking and rotational beams with an energy level of 6-10 MeV.
29 $176 $455
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
26 $97 $254
Radiation treatment management, 5 sessions
Oversight and management of a radiation therapy course consisting of five treatment sessions.
24 $151 $386
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
19 $70 $188
Continuing radiation therapy consultation per week
A weekly consultation to review and manage ongoing radiation therapy treatment.
17 $66 $163
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$76,627
Total received (2018-2024)
Avg $10,947/year across 7 years
Top 22% in OH for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
279
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$56,762 (74.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$14,153 (18.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,712 (7.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$943
2023
$1,516
2022
$9,782
2021
$11,491
2020
$2,583
2019
$32,690
2018
$17,623

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$147
Rigel Pharmaceuticals, Inc.
$114
SOBI, INC
$98
Novartis Pharmaceuticals Corporation
$71
Janssen Biotech, Inc.
$56
Daiichi Sankyo Inc.
$53
SpringWorks Therapeutics, Inc.
$50
E.R. Squibb & Sons, L.L.C.
$49
BeiGene USA, Inc.
$45
Tempus AI, Inc
$40
Sumitomo Pharma America, Inc.
$39
PharmaEssentia USA Corporation
$32
Kite Pharma, Inc.
$27
Gilead Sciences, Inc.
$23
Eisai Inc.
$23
Aveo Pharmaceuticals, Inc.
$21
Fennec Pharmaceuticals, Inc.
$20
Telix Pharmaceuticals
$20
Bayer Healthcare Pharmaceuticals Inc.
$13
Top 3 companies account for 38.1% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$54,288
Regeneron Healthcare Solutions, Inc.
$11,914
Apellis Pharmaceuticals, Inc.
$2,532
Rigel Pharmaceuticals, Inc.
$1,014
AVEO Pharmaceuticals, Inc.
$920
GlaxoSmithKline, LLC.
$555
Daiichi Sankyo Inc.
$363
Lilly USA, LLC
$346
Novartis Pharmaceuticals Corporation
$344
AstraZeneca Pharmaceuticals LP
$343
Janssen Biotech, Inc.
$301
Amgen Inc.
$227
Incyte Corporation
$225
BeiGene USA, Inc.
$201
Genmab U.S., Inc.
$200
PFIZER INC.
$198
Bayer HealthCare Pharmaceuticals Inc.
$188
Merck Sharp & Dohme LLC
$187
GT Medical Technologies, Inc
$165
Boehringer Ingelheim Pharmaceuticals, Inc.
$130
Astellas Pharma US Inc
$121
Takeda Pharmaceuticals U.S.A., Inc.
$110
Merck Sharp & Dohme Corporation
$107
Ipsen Biopharmaceuticals, Inc
$102
SOBI, INC
$98
Seagen Inc.
$97
Seattle Genetics, Inc.
$84
Celgene Corporation
$77
Alexion Pharmaceuticals, Inc.
$72
E.R. Squibb & Sons, L.L.C.
$70
Gilead Sciences, Inc.
$67
Janssen Pharmaceuticals, Inc
$67
Kite Pharma, Inc.
$58
Sumitomo Pharma America, Inc.
$57
SpringWorks Therapeutics, Inc.
$50
ABBVIE INC.
$50
EMD Serono, Inc.
$47
MEDIVATION FIELD SOLUTIONS LLC
$41
Eisai Inc.
$41
Tempus AI, Inc
$40
Array BioPharma Inc.
$39
AbbVie Inc.
$38
Foundation Medicine, Inc.
$38
TESARO, Inc.
$33
PharmaEssentia USA Corporation
$32
Novocure Inc.
$23
ARRAY BIOPHARMA INC
$23
SERVIER PHARMACEUTICALS LLC
$22
Pharmacosmos Therapeutics Inc.
$22
Aveo Pharmaceuticals, Inc.
$21
Pharmacyclics LLC, an AbbVie Company
$21
Fennec Pharmaceuticals, Inc.
$20
Telix Pharmaceuticals
$20
EISAI INC.
$20
Exelixis Inc.
$18
JAZZ PHARMACEUTICALS INC.
$18
Tactile Systems Technology Inc
$18
Dova Pharmaceuticals
$17
TG THERAPEUTICS, INC.
$17
GE HealthCare
$14
Advanced Accelerator Applications
$14
Bayer Healthcare Pharmaceuticals Inc.
$13
Servier Pharmaceuticals LLC
$13
Sobi, Inc
$12
Top 3 companies account for 89.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · Aliqopa · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABOMETYX · CARVYKTI · CERDELGA · CYRAMZA · DARZALEX · DISEASE STATE · DOPTELET · Doptelet · ELITEK · ENHERTU · ERLEADA · EXKIVITY · Enhertu · Epkinly · FOTIVDA · FOUNDATIONONE · Fabhalta · Flexitouch Plus · GILOTRIF · GammaTile · ILLUCCIX · IMBRUVICA · IMFINZI · JAKAFI · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lutathera · MEKINIST · MONOFERRIC · NINLARO · NO PRODUCT DISCUSSED · NUCALA · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OPDIVO · ORGOVYX · OXBRYTA · Oncology · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Pedmark · Pomalyst · REBLOZYL · Revlimid · Rezlidhia · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SUTENT · Stivarga · TIBSOVO · TUKYSA · Tavalisse · Trodelvy · UKONIQ · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · Vitrakvi · XARELTO · XGEVA · XTANDI · Yescarta · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (74%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware.

Looking for a hematology specialist in Cleveland?
Compare hematologists in the Cleveland area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sokol is a clinical cardiology specialist, with above-average Medicare volume (top 17% in OH), with speaking/promotional industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sokol experienced with intensity-modulated radiation therapy delivery?
Based on Medicare claims data, Dr. Sokol performed 153 intensity-modulated radiation therapy delivery services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sokol receive payments from pharmaceutical companies?
Yes. Dr. Sokol received a total of $76,627 from 64 companies across 279 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sokol's costs compare to other hematologists in Cleveland?
Dr. Sokol's average Medicare payment per service is $147. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sokol) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →